TO THE EDITORS:
Gil-Moreno et al. reported the single-institution experience of 87 consecutive cervical cancer patients treated by extraperitoneal laparoscopic staging before radiochemotherapy. 1 The data the authors present are in line with other studies on this issue documenting good safety and feasibility of the surgical procedure performed by experienced hands, as well as a convincing yield of laparoscopically dissected lymph nodes. 2 Furthermore, in this study, an excellent local tumor control could be achieved without any reported paraaortic tumor recurrences and with no significant differences in overall survival time and diseasefree survival time with respect to the paraaortic lymph node status.
However, the authors should provide further data so that we might discuss the selection of appropriate patients for this staging procedure. How were extraabdominal manifestations of the disease excluded before treatment? Have there been any positron emission tomography-computed tomographic studies, for example? For the 5 patients with positive paraaortic lymph nodes and disease-related death, was there any distant metastatic disease that potentially could have been detected earlier?
We ask our colleagues to comment on the selection process for this procedure so we can further optimize treatment algorithms for patients with advanced cervical cancer.
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